Vital Signs

Showing 11-20 of 307

20 Jan 2016  |  North America

Vital Signs - Medical Imaging Transitions Toward Value Focused Environment

Transforming Regulations, Reimbursement Models, Healthcare Objectives, and Multiple Stakeholders Usher in Era of Value Based Imaging

External and organic forces are acting in tandem on the medical imaging field: A trickle-down effect from healthcare reform and the Accountable Care Act, together with a transformation operated from within of its business models and value proposition, are combining to push the medical imaging industry decisively into a value-focused environment.\ ...

USD 750.00

USD 562.50 save 25 %

05 Jan 2016  |  Global

Vital Signs - Advances in Cancer Treatment, Clampdown on Specialty Pharmacies and Strategy Revamp for Sequencing Provider, An Analysis

Liquid Biopsy Test for Prostate Cancer and Non-small Cell Lung Cancer Treatment Show Promise

This issue of Vital Signs discusses MDxHealth's launch of the SelectMDx Liquid Biopsy Test in Europe, the FDA's approval of a new treatment for non-small cell lung cancer with EGFR mutations, the clamp down on specialty pharmacies by US drug benefit managers, and BGI's strategy redirection for Complete Genomics.

USD 450.00

USD 337.50 save 25 %

This research service presents an overview and analysis of the Australian contract research organization (CRO) market. The research service provides market revenue forecasts by phase and therapeutic type and discusses major issues and challenges, unmet needs, and developing trends in the CRO market. The study covers the complete life cycle of the C...

USD 450.00

USD 337.50 save 25 %

This research service presents an overview and analysis of the contract research organization (CRO) market. It provides revenue forecasts for the CRO market by phase and therapeutic type. The study discusses the key challenges, unmet needs, and emerging trends in the market and. It covers the complete life cycle of the CRO industry, starting from p...

USD 450.00

USD 337.50 save 25 %

This issue of Vital Signs discusses the FDA's clearnace of the first 3-D printed prescription drug, Illumina's formation of consumer genomics company Helix, Response Genetics' acquisition of Cancer Genetics, and Roche's acquisition of GeneWEAVE.

USD 450.00

USD 337.50 save 25 %

21 Sep 2015  |  North America

Vital Signs - Review of AHRA 2015: Key Conference Takeaways and Gadolinium Based MR Contrast Agents Safety Issues

Overview of Top Themes from the 2015 Annual Meeting of the Association for Medical Imaging Management (AHRA)

A record-high attendance of 1,000 radiology directors and managers convened to the 2015 Annual Meeting of the Association for Medical Imaging Management (AHRA 2015) held this year in Las Vegas. Radiology is going through interesting times indeed. Under the coordinated care paradigm that is gradually emerging in the U.S., and with all the changes th...

USD 450.00

USD 337.50 save 25 %

Sample preparation remains one of the largest headaches and bottlenecks in research, but is crucial to the success of downstream applications. While the market lacks the hype and excitement other hot technologies, the sample preparation market will always be a slow and steady gainer on an already large market size. Automation and application trends...

USD 450.00

USD 337.50 save 25 %

This study presents an overview and analysis of the South Korean contract research organization (CRO) market. It provides market revenue forecasts by phase and therapeutic type and discusses major issues and challenges, unmet needs, and emerging trends. The study covers the complete life cycle of the CRO market, from preclinical trials to post-mark...

USD 450.00

USD 337.50 save 25 %

The research service presents an overview and analysis of the China contract research organisation (CRO) market. It provides revenue forecasts by phase and therapeutic type and discusses the major issues and challenges, unmet needs, and emerging trends in the market. The study also covers the complete life cycle of the CRO industry, starting from p...

USD 450.00

USD 337.50 save 25 %

This market insight presents an overview and analysis of the Singaporean CRO market. It provides revenue forecasts for the CRO market by phase and therapeutic type. The research study discusses the major issues and challenges, unmet needs, and emerging trends in the market. The study covers the complete life cycle of the CRO industry, from preclini...

USD 450.00

USD 337.50 save 25 %

Showing 11-20 of 307